Evidence map›Paper›PMID 12748289›Full record

ArticleMolecular and cellular biology2003

Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4.

Jon Mar Björnsson, Nina Larsson, Ann C M Brun, Mattias Magnusson, Elisabet Andersson, Patrik Lundström, Jonas Larsson, Ewa Repetowska, Mats Ehinger, R Keith Humphries and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Molecular regulation of hematopoietic stem cell quiescence.Cellular and molecular life sciences : CMLS · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Cell cycle regulation of hematopoietic stem or progenitor cells.International journal of hematology · 2016
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jon Mar BjörnssonDepartment of Molecular Medicine and Gene Therapy, Lund University Hospital, Lund, Sweden.
Nina Larsson
Ann C M Brun
Mattias Magnusson
Elisabet Andersson
Patrik Lundström
Jonas Larsson
Ewa Repetowska
Mats Ehinger
R Keith Humphries
Stefan Karlsson
BC Cancer Agency · CALund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several homeobox transcription factors, such as HOXB3 and HOXB4, have been implicated in regulation of hematopoiesis. In support of this, studies show that overexpression of HOXB4 strongly enhances hematopoietic stem cell regeneration. Here we find that mice deficient in both Hoxb3 and Hoxb4 have defects in endogenous hematopoiesis with reduced cellularity in hematopoietic organs and diminished number of hematopoietic progenitors without perturbing lineage commitment. Analysis of embryonic day 14.5 fetal livers revealed a significant reduction in the hematopoietic stem cell pool, suggesting that the reduction in cellularity observed postnatally is due to insufficient expansion during fetal development. Primitive Lin(-) ScaI(+) c-kit(+) hematopoietic progenitors lacking Hoxb3 and Hoxb4 displayed impaired proliferative capacity in vitro. Similarly, in vivo repopulating studies of Hoxb3/Hoxb4-deficient hematopoietic cells resulted in lower repopulating capability compared to normal littermates. Since no defects in homing were observed, these results suggest a slower regeneration of mutant HSC. Furthermore, treatment with cytostatic drugs demonstrated slower cell cycle kinetics of hematopoietic stem cells deficient in Hoxb3 and Hoxb4, resulting in increased tolerance to antimitotic drugs. Collectively, these data suggest a direct physiological role of Hoxb4 and Hoxb3 in regulating stem cell regeneration and that these genes are required for maximal proliferative response.

Indexed as

AnimalsAntimetabolitesBone Marrow TransplantationCell DivisionFluorouracilGene TargetingHematopoiesisHematopoietic Stem CellsHomeodomain ProteinsLiverMiceMice, KnockoutTranscription FactorsXenopus ProteinsAntimetabolitesFluorouracilHomeodomain ProteinsHox 2.7 protein, XenopusHoxb4 protein, mouseTranscription FactorsXenopus Proteins

Identifiers

PMID12748289
PMCPMC155209
OpenAlexW2170664615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.